Onsdag 12 Mars | 12:22:50 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-02-27 N/A Bokslutskommuniké 2025
2025-08-21 07:30 Kvartalsrapport 2025-Q2
2025-04-04 N/A X-dag ordinarie utdelning GUBRA 0.00 DKK
2025-04-03 N/A Årsstämma
2025-02-28 - Bokslutskommuniké 2024
2024-08-23 - Kvartalsrapport 2024-Q2
2024-04-04 - X-dag ordinarie utdelning GUBRA 0.00 DKK
2024-04-03 - Årsstämma
2024-02-28 - Bokslutskommuniké 2023
2023-11-01 - Extra Bolagsstämma 2023
2023-08-25 - Kvartalsrapport 2023-Q2

Beskrivning

LandDanmark
ListaMid Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
Gubra är ett läkemedelsbolag. Bolagets verksamhet är fokuserad på de tidiga stadierna av läkemedelsutveckling. De driver huvudsakligen forskning och utveckling inom området för metabola och fibrotiska sjukdomar.. Bolagets produktportfölj innefattar ett flertal varumärken och läkemedel, och verksamheten bedrivs på global nivå, med störst närvaro inom Nordamerika och Norden. Huvudkontoret ligger i Hørsholm, Danmark.
2025-01-15 07:30:00

Gubra is excited to announce the appointment of Anne-Marie Levy Rasmussen as the company’s new Chief Operating Officer (COO). Anne-Marie brings a strong international experience and track record from global pharma companies such as GlaxoSmithKline and Bavarian Nordic within operational leadership, scaling and establishment of solid governance routines in complex settings. Most recently as Head of Global Commercial Operations at Bavarian Nordic.

As COO in Gubra, Anne-Marie will be member of the Executive Management Team and be responsible for overseeing the company's operational strategy, optimizing processes, and driving efficiency across departments and key projects. Her extensive background within leadership, scaling and system integration with new digital approaches positions her well to contribute to Gubra's continued growth and innovation. Anne-Marie’s theoretical background is a MSc Physics from University of Copenhagen.

"We are thrilled to welcome Anne-Marie to the Gubra team," said Henrik Blou, CEO of Gubra. "Her proven track record from global pharma companies and approach to operational excellence will be instrumental as we continue to grow and optimize Gubra."

Anne-Marie expressed enthusiasm about joining Gubra, stating, "I’m very excited to join Gubra as COO. I look forward to contributing to the company’s continued growth and delivering on the strategy and to collaborate with the very skilled and passionate employees at Gubra."